Kura Oncology 's growing cancer drug sales and promising pipeline could fuel a rally in its stock, according to JPMorgan. Analyst Priyanka Grover initiated coverage with an overweight rating and a ...
VitroVivo Biotech LLC, a Maryland-based provider of histology and molecular histopathology products and laboratory services, is expanding access to specialized tissue-based research support through ...
Biotech leader BeOne stock is poised to hit multiple buy points. Its blockbuster drug generated $1.2 billion in sales in the ...
Kodiak Sciences tripled in a single session after its eye drug cleared a pivotal trial, but a cash-burning biotech with no ...
Oneness Biotech completed the SAD portion of its Phase 1 trial evaluating SNS851 as a potential treatment for ...
Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today announced data published in the Proceedings of the ...
Stocktwits on MSN
Biotech lagged the broader market in September — did retail favorites SLS, IBRX, VNDA and IOVA dodge XBI’s slump?
Sellas reported preclinical pancreatic cancer findings for SLS009 as investors awaited the Phase 3 Regal leukemia readout for ...
Morgan Stanley highlights 3 biotech breakthroughs in Alzheimer's, gene editing, and AI that could shape investor returns.
Dozens of biotech executives are convening in Washington today to warn that insufficient federal policy planning could result ...
The following biotech stocks reached a 52-week high on September 17, 2026, driven by the gain on certain clinical or financial results. MediciNova Inc. (MNOV) MediciNova functions as a ...
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced the launch of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results